Results 141 to 150 of about 391,028 (345)

Aggressive prostate cancer is associated with pericyte dysfunction

Molecular Oncology, EarlyView.
Tumor‐produced TGF‐β drives pericyte dysfunction in prostate cancer. This dysfunction is characterized by downregulation of some canonical pericyte markers (i.e., DES, CSPG4, and ACTA2) while maintaining the expression of others (i.e., PDGFRB, NOTCH3, and RGS5).
Anabel Martinez‐Romero, Ane Martinez‐Larrinaga, Joaquim Grego‐Bessa, Saioa Garcia‐Longarte, Hielke van Splunder, Ianire Astobiza, Amaia Ercilla, Laura Bozal‐Basterra, Isabel Mendizabal, Pilar Villacampa, Arkaitz Carracedo, Mariona Graupera   +11 more
wiley   +1 more source

Liberalizing abortion to reduce maternal mortality: expanding access to all Ethiopians

Reproductive Health, 2022
Mekdes Daba Feyssa, Saba Kidanemariam Gebru   +1 more
doaj   +1 more source

The association between reproductive rights and access to abortion services and mental health among US women. [PDF]

SSM Popul Health, 2023
Liu SY, Benny C, Grinshteyn E, Ehntholt A, Cook D, Pabayo R.   +5 more
europepmc   +1 more source

The Right to (Trans) Parent: A Reproductive Justice Approach to Reproductive Rights, Fertility, and Family-Building Issues Facing Transgender People

, 2013
In focusing on fertility preservation and the whiff of eugenics in state statutes, this Article aims to make several contributions to issues at the intersection of the LGBT and reproductive health, rights, and justice movements.
Nixon, Laura
core  

The State of Reproductive Health and Rights: 50 State Report Card [PDF]

, 2014
The status of reproductive health and rights in the U.S. is at an historic crossroads. At the federal level, the Affordable Care Act is expanding insurance coverage for reproductive health services, but at the state level political assaults on Planned ...

core  

Tumor and germline testing with next generation sequencing in epithelial ovarian cancer: a prospective paired comparison using an 18‐gene panel

Molecular Oncology, EarlyView.
Genetic testing in epithelial ovarian cancer includes both germline and tumor‐testing. This approach often duplicates resources. The current prospective study assessed the feasibility of tumor‐first multigene testing by comparing tumor tissue with germline testing of peripheral blood using an 18‐gene NGS panel in 106 patients.
Elisabeth Spenard, Cristina Mitric, Melanie Care, Tracy L. Stockley, Raymond H. Kim, Jeanna McCuaig, Blaise Clarke, Laura Ranich, Clare Sheen, Sarah E. Ferguson, Liat Hogen, Taymaa May, Marcus Q. Bernardini   +12 more
wiley   +1 more source

Reproductive Rights

International Journal of Science and Research (IJSR)
Schurr, Carolin, Militz, Elisabeth, Kobayashi, Audrey   +2 more
  +5 more sources

A pronatalist turn in population policies in Iran and its likely adverse impacts on reproductive rights, health and inequality: a critical narrative review. [PDF]

Sex Reprod Health Matters, 2023
Asadisarvestani K, Sobotka T.
europepmc   +1 more source

Surrogacy Versus Reproductive Rights: A Legal Perspective

, 2022
Abiade Abiola
openalex   +1 more source

The neural crest‐associated gene ERRFI1 is involved in melanoma progression and resistance toward targeted therapy

Molecular Oncology, EarlyView.
ERRFI1, a neural crest (NC)‐associated gene, was upregulated in melanoma and negatively correlated with the expression of melanocytic differentiation markers and the susceptibility of melanoma cells toward BRAF inhibitors (BRAFi). Knocking down ERRFI1 significantly increased the sensitivity of melanoma cells to BRAFi.
Nina Wang, Qian Sun, Daniel Novak, Lei Zhu, Juliane Poelchen, Tamara Steinfass, Yiman Wang, Viktor Umansky, Jochen Utikal   +8 more
wiley   +1 more source